Deutsche Bank
MAZE

Deutsche Bank’s Maze Therapeutics MAZE Stock Holding History

Deutsche Bank’s Portfolio MAZE Stock Details MAZE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.04M Buy
34,993
+14,730
+73% +$386K ﹤0.01% 2324
2026
Q1 		$605K Buy
20,263
+4,741
+31% +$209K ﹤0.01% 2472
2025
Q4 		$643K Buy
15,522
+6,637
+75% +$228K ﹤0.01% 2439
2025
Q3 		$230K Hold
8,885
– – ﹤0.01% 2989
2025
Q2 		$109K Hold
8,885
– – ﹤0.01% 3218
2025
Q1 		$97.8K Buy
+8,885
New +$107K ﹤0.01% 3203

Other funds holding MAZE

TGI
TRV GP IV Boston, Massachusetts $254M AUM 426.76% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
AI
Alphabet Inc Mountain View, California $99.1B AUM 124.46% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
TGV
TRV GP V Boston, Massachusetts $498M AUM 267.53% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return
MGB
Mass General Brigham Somerville, Massachusetts $361M AUM
Walleye Capital
Walleye Capital New York $28B AUM 44.22% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
AA
ALPS Advisors Denver, Colorado $21.3B AUM 23.41% 1-Year Est. Return

Deutsche Bank's MAZE Position: Q2 2026 in Review

Deutsche Bank increased its Maze Therapeutics (MAZE) stake by 73% in Q2 2026, buying an estimated $386K and bringing the position to 34,993 shares worth $1.04M. The position accounts for ﹤0.01% of the portfolio, ranked #2324.

Deutsche Bank first reported a position in MAZE in Q1 2025 and has held it in 6 quarters since. 46 funds tracked by Wall St. Rank hold MAZE as of Q2 2026.

  • Deutsche Bank held 34,993 shares of Maze Therapeutics worth $1.04M as of Q2 2026.
  • Deutsche Bank bought 14,730 Maze Therapeutics shares in Q2 2026, an estimated $386K.
  • Maze Therapeutics made up ﹤0.01% of Deutsche Bank's portfolio in Q2 2026, its #2324 holding.
  • Deutsche Bank first reported a position in Maze Therapeutics in Q1 2025 and has held it in 6 quarters since.
  • 46 funds tracked by Wall St. Rank held Maze Therapeutics as of Q2 2026.

Based on Deutsche Bank's 13F filing for Q2 2026, filed 7 Aug 2026.